National News

WHO data show Malawi made progress in TB fight

World Health Organisation (WHO) data show that Malawi has made remarkable progress in the fight against tuberculosis (TB) by cutting incidence and deaths sharply over the past 10 years.

Malawi’s estimated TB incidence rate now stands at 107 per 100 000 people, down from 198 in 2015, a change experts say reflects steady gains in prevention, diagnosis and treatment.

That figure represents a 46 percent reduction in TB incidence since 2015, bringing Malawi close to the 50 percent milestone set under the global End TB Strategy for the year 2025 in total.

Touted scaling up ART:Matemba.

On the other hand, deaths caused by TB have also fallen as an estimated 4 100 people died from TB in 2025, with an uncertainty interval of 2 500 to 6 100 deaths across the entire nation this year in total, down from about 12 100 deaths in 2025.

This represents a 66 percent reduction in TB deaths since 2015, approaching the ambitious 75 percent milestone for 2025 and moving Malawi toward the 90 percent target for 2030 and beyond now overall.

Reads the WHO report: “A reduction in both total funding and USG [Government of the United States of America] bilateral funding between 2024 and 2025. This category comprises nine countries: Bangladesh, Cambodia, Ethiopia, Malawi, Myanmar, Nigeria, Tajikistan, Ukraine and Zimbabwe.”

There is also registered progress against drug-resistant TB as the proportion of Rifampicin-Resistant TB (RR-TB) among new cases fell from about 2.1 percent in 2015 to below one percent by 2025.

Among previously treated cases, RR-TB declined from about six percent in 2015 to about five percent in 2025, showing better treatment completion and follow-up for patients at highest risk nationwide in Malawi today overall.

The estimated number of people who developed RR-TB fell from 1 000 in 2015 to 400 in 2025, easing pressure on specialised treatment centres and drug supplies nationwide in Malawi today overall.

Despite gains, men aged 25 to 44 still carry the highest TB burden in 2025. Health officials say targeted screening, HIV testing and community outreach must continue to sustain progress for all Malawians nationwide.

International Coalition on Health Financing Advocacy chairperson Maziko Matemba said TB in Malawi has historically been driven by HIV co-infection, such that scaling-up of antiretroviral therapy (ART) and integrated HIV-TB screening has been a decisive factor in cutting mortality rates.

With financing challenges, he urged government to prioritise domestic treasury allocations specifically for essential first- and second-line TB drugs and diagnostic cartridges.

Meanwhile, WHO Department for HIV, Tuberculosis, Hepatitis and Sexually Transmitted Infections director Tereza Kasaeva has said the achievement demonstrates what is possible when commitment is translated into action.

She said: “But we cannot lose sight of the millions of people who are still not reached with the TB prevention, diagnosis, treatment and care they need.

“WHO is working with countries to build on this momentum, expanding access to rapid diagnosis and effective treatment and bringing new tools and innovations to the people who need them.”

Globally in 2025, the TB incidence rate was 129 new cases per 100 000 populations, a 1.6 percent decline compared with 131 in 2024 and 14 percent decrease from 2015.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Back to top button